Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive Disorder

NCT02194075 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Obsessive Compulsive Disorder

Interventions

DRUG: Fluvoxamine+Methylphenidate hydrochloride
DRUG: Fluvoxamine+sugar pill

Sponsor

Guangdong Provincial People's Hospital